ddp4 and glp 1 together Mechanism of action for GIP, GLP-1 analogues DPP4 inhibitors in Neuroprotection by dipeptidyl-peptidase-4 inhibitors and
Description
But theyre not.

The benefits observed in studies to date depend on achieving and maintaining therapeutic dose ranges over time

Therapeutic Advances in Endocrinology and Metabolism, 12

doi:10.1016/j.obpill.2022.100047

The American Academy of Pediatrics endorsed GLP-1 medications for patients 12 and older with obesity in 2023, legitimizing their use in pediatric weight management

This case series provides patient-level data that complement the findings of a meta-analysis by He et al of the association of cholecystitis with GLP-1 receptor agonists, the researchers wrote
